Home › NCT07150923
Supraglottic Airway for Resuscitation Trial
Recruiting
Comparing Two Multicomponent Strategies To Promote Supraglottic Airway Implementation During Neonatal Resuscitation
Who can join
0 Days · All sexes
Full eligibility criteria
Population 1: Hospital Staff Population 1a: Clinical providers and administrators who complete study questionnaires Clinical provider 1a inclusion criteria: * Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation * Fluent in English Administrator 1a inclusion criteria * Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer) * Fluent in English Clinical provider and administrator exclusion 1a criteria: No exclusion criteria Population 1b: Clinical providers who participate in qualitative interviews Clinical provider 1b inclusion criteria: * Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation * Fluent in English Clinical provider 1b exclusion criteria: No exclusion criteria Population 2: Patients who receive neonatal resuscitation at birth Inclusion Criteria: * Inborn (not transferred to the hospital after birth) * ≥34 weeks' gestation at birth, based on best obstetrical estimate * Received PPV during neonatal resuscitation (as per provider's clinical assessment) Exclusion Criteria: * Congenital diaphragmatic hernia * Airway anomalies
About the study
This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.
What is being tested
- Enhanced Standard of Care ("Enhanced") (other)
- Enhanced Standard of Care ("Enhanced-Plus") (other)
Sponsor: Children's Hospital of Philadelphia · Participants: 36,503 · Started: Jan 1, 2026
Contact the study team
- Elizabeth E Foglia, MD, MSCE · Phone: 215-590-1653
Official record on ClinicalTrials.gov — NCT07150923
Locations in the U.S.
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.